Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Does not change clinical practice; extends molecular framework of hypertrophy and leaves open therapeutic targets for validation.
Ventricular hypertrophy is an ominous escalation of hemodynamically stressful conditions such as hypertension and valve disease. The pathophysiology of hypertrophy is complex and multifactorial, as it touches on several cellular and molecular systems. Understanding the molecular background of cardiac hypertrophy is essential in order to protect the myocardium from pathological remodeling, or slow down the destined progression to heart failure and cardiomyopathy. In this review we highlight the most important molecular aspects of cardiac hypertrophic growth in light of the currently available published research data.
No takes yet. Share an insight, caveat, or question.
Samak et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: